Skip to main content

Table 1 Discrete Baseline Characteristics

From: Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning

 

Patient Percentage (%)

Demographic

 Male

50.4

 Type 1 Diabetes Mellitus

7.37

Comorbidities

 Hypertension

35.6

 Ophthalmological Complications

32.2

 Ischemic Heart Disease

16.2

 Ischemic Stroke and Transient Ischemic Attack

11.8

 Heart Failure

9.8

 Chronic Renal Disease

8.8

 Chronic Liver Disease

5.8

 Acute Myocardial Infarction

5.1

 Chronic Obstructive Pulmonary Disease

3.5

Anti-diabetic Medication

 Biguanide

57.6

 Sulphonylurea

41.5

 Thiazolidinedione

3.5

 Alpha-Glucosidase

3.0

 Dipeptidyl Peptidase-4 Inhibitor

0.4

 Glucagon-Like Peptide-1 Receptor Agonist

< 0.1

Cardiovascular medication

 Angiotensinogen-Converting Enzyme Inhibitor/ Angiotensin-Receptor Blocker

59.8

 Calcium Channel Blocker

43.6

 Lipid-Lowering Agents

42.4

 Aspirin

36.2

 Diuretic

29.2

 Beta-Adrenergic Receptor Blocker

28.1